Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Cancers|April 12, 2022
Upregulation of PSMA Expression by Enzalutamide in Patients with Advanced mCRPCFlorian Rosar, Robert Neher, Caroline Burgard, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 27, 2023
Change in total lesion PSMA (TLP) during [177Lu]Lu-PSMA-617 radioligand therapy predicts overall survival in patients with mCRPC: monocentric evaluation of a prospective registryCaroline Burgard, Connor Hein, Arne Blickle, et al.
Nuclear Medicine and Molecular Imaging|January 30, 2025
Harnessing Terbium Radioisotopes for Clinical Advancements: A Systematic ReviewAhmed Saad Abdlkadir, Florian Rosar, Amireza Jalilian, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 6, 2023
Detection efficacy of [89Zr]Zr-PSMA-617 PET/CT in [68Ga]Ga-PSMA-11 PET/CT-negative biochemical recurrence of prostate cancerFlorian Rosar, Fadi Khreish, Robert J Marlowe, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 3, 2025
Tumor sink effect in PSMA-targeted theranostics: intra-patient evaluation of a cohort receiving 225Ac/177Lu-PSMA tandem radioligand therapyCaroline Burgard, Marie D Muenzenberg, Arne Blickle, et al.
Journal of Medicinal Chemistry|April 7, 2021
Identification, Characterization, and Suppression of Side Products Formed during the Synthesis of [177Lu]Lu-PSMA-617Sebastian Martin, Roswitha Tönnesmann, Ina Hierlmeier, et al.
Nuclear Medicine and Biology|June 1, 2025
Radiochemistry of cyclen-derived chelators comprising five-membered azaheterocyclic arms with 212Pb2+, 213Bi3+, and 225Ac3Ina Hierlmeier, Parmissa Randhawa, Brooke L McNeil, et al.
Pageof 10